PAULS MATTHEW sold 5.2% of their position (786.00 shares) of PELTHOS THERAPEUTICS INC. on the open market
Open‑market sale worth $20.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/7/2026ACC: 0001919246-26-000101
-786.00
Net shares
Net seller
$20.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
786.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−692.00
Price / share
$26.00
Trade value
$17.99K
% of position
4.6%
7/2/2026
15.15K→14.46K
Common Stock
Direct
Shares
−94.00
Price / share
$27.36
Trade value
$2.57K
% of position
0.7%
7/2/2026
14.46K→14.36K
Total
Net shares
−786.00
Net value
-$20.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | S · Sale | −692.00 | $26.00 | $17.99K | 4.6% | 15.15K | 14.46K |
| Common Stock Direct | 7/2/2026 | S · Sale | −94.00 | $27.36 | $2.57K | 0.7% | 14.46K | 14.36K |
| Total | −786.00 | -$20.56K | ||||||
Derivative Transactions0
No derivative transactions reported